Every cancer is different. Because of that, researchers have for decades been working on personalised cancer vaccines designed to make the immune system recognise and attack cancers specific to each individual. The results have been mixed, but now a personalised cancer vaccine has produced positive results in a final-stage trial for the first time.
Moderna announced on 19 August that people who had undergone surgery to remove severe skin cancers, called melanomas, survived longer without the cancer returning or spreading to other parts of the body if they were given a personalised mRNA cancer vaccine in conjunction with another immunotherapy, compared with receiving that immunotherapy alone…
Source: NewScientist | Health
NewScientist
- Super El Niño set to cause ‘terribly dangerous’ drought in the Amazon
- I made a free AI chatbot solve a decade-long maths problem in 13 minutes
- We’re on the verge of seeing the quantum vacuum for the first time
- The best new popular science books of September 2026
- Laughter therapy may help people with chronic lung disease
NewScientist | Earth
- Exploring the world’s northernmost caves – in pictures
- Asteroid strike caused global firestorm that incinerated the dinosaurs
- Negatives saved from Shackleton’s Antarctic trip reveal hidden details
- A volcano has erupted remnants of Earth’s primordial magma ocean
- Huge crater in Australia may be the oldest impact structure on Earth
NewScientist | Health
- Laughter therapy may help people with chronic lung disease
- How worried should we be about the invasive mosquitoes in the UK?
- Pig kidney kept a man off dialysis for nine months in world first
- Psilocybin could prevent common and debilitating chemotherapy side effect
- The science behind an ambitious cancer strategy
